Skip to main content

BioVenture — Portfolio, Page 10

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

274
Companies
$1.0B
Total invested
$20.1M
Avg. check
30
Industries
Health Care 16Biotechnology 13Medical 8Biopharma 5Therapeutics 5Medical Device 5+24 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 217240 of 274
Pathware
April 2022

Pathware is creating hardware and software to simplify digital pathology workflows.

Computer · Golden$7.0M Series A
Freeline
March 2022

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Biopharma · Stevenage$26.1M Post Ipo Equity
CART Medical
March 2022

CART Medical is a high-tech company specializing in the development and application of new technologies for immune cell therapy.

Health Care · Nanjing$11.1M Series A
NeuroEchos
February 2022

NeuroEchos is an innovative medical device and intelligent diagnosis service provider.

Health Care · Baoan$15.8M Series A
Arkuda Therapeutics
February 2022

Arkuda Therapeutics is a pharmaceutical company.

Biotechnology · Cambridge$64.0M Series B
NeighBor Doc
February 2022

NeighBor Doc is an online platform that provides healthcare services.

Health Care · Hangzhou$15.7M Series A
Enzymaster
January 2022

Enzymaster focuses on the development and commercialization of enzymes for the innovative and sustainable production of API intermediates.

Agriculture · Ningbo$47.4M Series C
Curbside Health
January 2022

Improving medical decision making through an EHR-integrated B2B SaaS platform for hospitals and front-line clinicians.

Electronic Health Record (EHR) · San Francisco$3.7M Seed
Shengshi Technology
January 2022

Shengshi Technology is a CFD experimental simulation AI-based platform that does medical engineering research on cardiovascular diseases.

CAD · Hangzhou$15.7M Seed
Zhengli Technology
December 2021

Zhengli Technology is a medical technology company engaged in the research, production, and sales of invisible orthodontic products.

Dental · Tianjin$15.7M Series C
Yuanjingtaico
December 2021

Yuanjingtaico is a biotech firm focused on the R&D of fluorescent PCR reagents, microfluidic, and electrochemical detection products.

Biotechnology · Tongzhou$1.6M Seed
Yidianling
December 2021

Yidianling is an online psychological counselling platform that provides free questions and answers, psychological tests & expert services.

Health Care · Shanghai$31.4M Series B
ITabMed
December 2021

ITabMed's aim of "Innovating for Life" continues, with a focus on the discovery and development of cancer immunotherapy treatments.

Biopharma · Shanghai$20.0M Series A
SanReno Therapeutics
November 2021

SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies.

Biotechnology · Beijing$40.0M Undisclosed
KingstronBio
November 2021

KingstronBio manufactures artificial heart valves and annuloplasty rings.

Manufacturing · Changshu$47.0M Series C
Treadwell Therapeutics
November 2021

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

Biotechnology · New York$91.0M Series B
Cellevolve
November 2021

Cellevolve Inc is a development and commercialization company focused on cell therapies.

Biotechnology · San Francisco$6.0M Seed
eGlint
November 2021

Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.

Analytics · San Diego$2.4M Seed
Changmugu Medical
November 2021

Changmugu Medicalis an artificial intelligence (AI)-powered healthcare start-up providing AI-powered surgical robot solutions.

Artificial Intelligence (AI) · Beijing$84.5M Series B
Hopstem
October 2021

Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.

Biotechnology · Hangzhou$40.0M Series B
BiOligo
October 2021

Bioligo establishes and provides high-quality DNA synthesis/sequencing, experiments, production and various customized services.

Biotechnology · Songjiang$47.0M Series A
Creative Biosciences
October 2021

Creative Biosciences is a biomedical technology company.

Biopharma · Guangzhou$87.0M Series D
DeepSight Technology
October 2021

DeepSight Technology's vision is to reinvent diagnostic imaging.

Medical Device · San Francisco$25.0M Series A
IpiNovyx Bio
October 2021

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

Biopharma · West Nyack$10.0M Seed

Where BioVenture invests

Health Care16
Biotechnology13
Medical8
Biopharma5
Therapeutics5
Medical Device5

About BioVenture's portfolio

How many companies has BioVenture invested in?

BioVenture has invested in 274 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?

BioVenture's top investment sectors include Health Care, Biotechnology, Medical, Biopharma, Therapeutics. The firm invests across 30 different industry categories.

What is BioVenture's largest investment?

Among tracked funding rounds, Treadwell Therapeutics received $91.0M in a Series B round. BioVenture's total known invested capital is $1.0B.

What is the average investment size for BioVenture?

BioVenture's average investment size is $20.1M across its portfolio of 274 companies.

What are BioVenture's most recent investments?

Recent BioVenture portfolio additions include Pathware, Freeline, CART Medical, NeuroEchos, Arkuda Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 274 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →